Sun Pharmaceutical Industries Ltd initiated setting up of treatment and recycling plants, through registered recyclers and engaged scrap vendors for materials like plastic and high-density polyethylene (HDPE). Systematic processes (SOPs) are…Read More
Shares of Granules India fell 3% in the noon trade after USFDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the company at Chantilly,…Read More
GE Healthcare today unveiled ‘Edison – Startups powered by GE Healthcare’ – its first startup collaboration program centered on the Edison platform. The program will work with startups in India…Read More
GE Healthcare unveiled ‘Edison – Start-ups powered by GE Healthcare’ its first start-up collaboration programme centred on the Edison platform, in Bengaluru on Wednesday. Zinnov, a consulting firm specialising in…Read More
Shares of the pharmaceutical company rose 2.04% to Rs 520.75 after a successful USFDA inspection at the company’s Vadodara facility. Alembic Pharmaceuticals announced after market hours yesterday, 20 August 2019,…Read More
Shares of Sun Pharma Advanced Research Company declined more than 3 percent in the early trade on August 21 after a US firm filed a complaint against the company in the US…Read More
1. Bull market or bear market today? Nifty is expected to maintain its consolidation pattern, given the weak macroeconomic situation prevalent in domestic as well as in the global economy….Read More
After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India, behind it. The FDA has indicated that Sun’s improvements have reached a…Read More
Shares of the pharmaceutical company rose 1.81% to Rs 367.65 on bargain hunting after a recent steep fall. The scrip plunged 15.29% in the past three trading sessions to settle…Read More
Annaswamy Vaidheesh, vice president -South Asia and India MD of Glaxosmithkline Pharmaceuticals, spoke to CNBC-TV18 about the company’s business plans and shared growth outlook. “We have launched the programme of…Read More
Sun Pharma share price rose in early trade today after US health regulator referred to company’s Halol Plant as ‘No Action Indicated’. No Action Indicated means no objectionable conditions or…Read More
SUN Q1FY20 reported EPS came 40% ahead of JEFe led by lower R&D and tax rate. Adj. for these margins were 100bps and EPS 15% ahead. RoW business revenues were…Read More
The BSE Healthcare Index hit an all-time low last week and continues to trade weak due to multiple headwinds. Despite easing competitive intensity in the US and lower price erosion,…Read More
Sun Pharma Industries Ltd. announced on August 16 that it has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in mainland China….Read More
Lonza India, a wholly-owned subsidiary of Switzerland-based integrated solutions provider for pharma and consumer healthcare, announced its India plan. India being a strategic market for the company, Lonza India with…Read More